CoChat

Glucosamine-Induced Inhibition of Liver Glucokinase Impairs the Ability of Hyperglycemia to Suppress Endogenous Glucose Production

Barzilai, Nir, Hawkins, Meredith, Angelov, Ivo, Hu, Meizhu, Rossetti, Luciano · 1996 · Diabetes
Cited by 62

The DOI matches its Crossref record.

Abstract

Although the kinetic characteristics of hepatic glucokinase (GK) suggest its potential role as the hepatic “glucose sensor,” its impact on the regulation of in vivo hepatic glucose production (HGP) is still controversial. Since decreased GK activity has been linked to experimental and human diabetes, we examined whether a moderate and transient inhibition of GK activity diminishes the ability of hyperglycemia to suppress HGP. We first determined the concentration of the competitive inhibitor, glucosamine (GlcN), which decreases hepatic GK activity by ∼ 60% in vitro. GlcN was then infused into conscious rats to achieve a similar inhibition of the in vivo GK activity (plasma GlcN levels = ∼ 2 mmol/l; rats infused with saline served as control, n = 20). To maintain equal plasma insulin and glucagon concentrations throughout the studies, somatostatin and insulin (basal replacement) were infused for 4 h. [3-(3H)]-glucose and [U-(14C)]-lactate were infused to measure HGP, gluconeogenesis, and glucose cycling (GC) during 2 h of euglycemia (glucose ∼ 8 mmol/l) followed by 2 h of hyperglycemia (glucose ∼ 18 mmol/l). Our results support the notion that hepatic GK activity is indeed decreased by GlcN in vivo. In fact, in response to hyperglycemia the “direct” pathway of hepatic glucose-6-phosphate (G-6-P) formation was ∼ 40% lower with GlcN compared with saline infusion (37 ± 3 vs. 63 ± 3%; P < 0.001). Furthermore, while hyperglycemia stimulated GC by ∼ 2.5-fold during saline infusion (from 3.0 ± 0.6 to 7.7 ± 1.4 mg.kg−1 · min−1, P < 0.001, euglycemia vs. hyperglycemia), this increase was blunted in the presence of GlcN (4.6 ± 0.6 mg.kg−1 · min−1, P = NS). Finally, in the presence of GlcN, the hepatic concentration of G-6-P was decreased by ∼ 40% compared with saline (234 ± 38 and 390 ± 24 nmol/g, P < 0.01). During the euglycemic studies, HGP was similar (12.6 ± 0.6 and 11.3 ± 0.2 mg .kg−1 · min−1 with GlcN or saline infusion, respectively). However, while hyperglycemia per se suppressed HGP by ∼ 65%, HGP was inhibited by ∼ 38% and it was ∼ twofold higher than in the saline-infused rats (7.8 ± 0.8 and 4.0 ± 0.3 mg.kg−1 · min−1, P < 0.01) in the presence of GlcN-induced inhibition of hepatic GK. This increase in HGP was largely accounted for by the decreased inhibition of hepatic net glycogenolysis by hyperglycemia (3.3 ± 0.8 and 1.1 ± 0.3 mg.kg−1 · min−1 with GlcN or saline infusion, respectively, P < 0.01). We conclude that intact GK activity is required for the normal suppression of HGP by hyperglycemia and its impairment may contribute to increased HGP in experimental and human diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diab.45.10.1329

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 62

Metadata

Authors
Barzilai, N., Hawkins, M., Angelov, I., Hu, M., & Rossetti, L.
Venue
Diabetes
Published
1996-10-01
Volume
45
Issue
10
Pages
1329-1335
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2161848146
Cited by
62
References
0
FWCI
4.58
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glucosamine-Induced Inhibition of Liver Glucokinase Impairs the Ability of Hyperglycemia to Suppress Endogenous Glucose Production. https://app.cochat.ai/papers/10.2337/diab.45.10.1329
The paper
Barzilai, N., Hawkins, M., Angelov, I., Hu, M., & Rossetti, L. (1996). Glucosamine-Induced Inhibition of Liver Glucokinase Impairs the Ability of Hyperglycemia to Suppress Endogenous Glucose Production. Diabetes. https://doi.org/10.2337/diab.45.10.1329

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.